文献速递心脑血管急症重症综合管理与镇静镇痛

入院时间与发病时间对心源性休克患者预后的影响

Effect of Admission and Onset Time on the Prognosis of Patients With Cardiogenic Shock.
PubMed 文献 · Chest · 2023-08-12
一句话结论院外原发性心源性休克在非工作时间入院者30天全因死亡风险低于工作时间入院者(HR 0.497)。

该前瞻性单中心注册研究连续纳入2019至2021年273例任何病因的心源性休克患者,其中64%为院外原发性心源性休克。分析显示,心源性休克发病地点(院外原发 vs 住院继发)与全队30天全因死亡风险无显著关联(继发性院内CS:HR 1.532,95%CI 0.990-2.371,P=0.06);但AMI相关继发性院内CS的30天全因死亡风险升高(HR 2.087,95%CI 1.126-3.868,P=0.02)。院外原发性CS在非工作时间入院者较工作时间入院者30天全因死亡风险更低(HR 0.497,95%CI 0.302-0.817,P=0.01),无论是否合并AMI。

要点

  • 院外原发性CS在非工作时间入院者30天全因死亡风险低于工作时间入院者(HR 0.497,95%CI 0.302-0.817,P=0.01),无论是否合并AMI。
  • AMI相关继发性院内CS患者30天全因死亡风险升高(HR 2.087,95%CI 1.126-3.868,P=0.02)。
  • 全队列中继发性院内CS与原发性院外CS的30天全因死亡风险无显著差异(HR 1.532,95%CI 0.990-2.371,P=0.06)。
  • 研究为前瞻性单中心注册,连续纳入2019至2021年273例任何病因CS患者,64%为院外原发性CS。

适用人群与场景

  • 2019至2021年连续纳入的任何病因心源性休克患者,共273例,其中64%为院外原发性心源性休克。

研究设计与关键结果

  • 研究类型:前瞻性单中心注册研究,连续纳入2019至2021年273例任何病因心源性休克患者,64%为院外原发性CS。
  • 主要分析:全队列中继发性院内CS与原发性院外CS的30天全因死亡风险无显著差异(HR 1.532,95%CI 0.990-2.371,P=0.06)。
  • 亚组分析:AMI相关继发性院内CS患者30天全因死亡风险升高(HR 2.087,95%CI 1.126-3.868,P=0.02)。
  • 时间分析:院外原发性CS在非工作时间入院者较工作时间入院者30天全因死亡风险更低(HR 0.497,95%CI 0.302-0.817,P=0.01),无论是否合并AMI。

证据类型、等级与局限

  • 证据类型:前瞻性单中心注册研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,原发性和继发性CS的30天全因死亡风险相当,而院外原发性CS在非工作时间入院与30天全因死亡风险降低相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The spectrum of patients with cardiogenic shock (CS) has changed significantly over time. CS has become especially more common in the absence of acute myocardial infarction (AMI), while this subset of patients was typically excluded from recent studies. Furthermore the prognostic impact of onset time and onset place due to CS has rarely been investigated.

RESEARCH QUESTION: Do the place of CS onset (out-of-hospital, ie, primary CS vs in-hospital, ie, secondary CS) and the onset time of out-of-hospital CS (ie, on-hours vs off-hours admission) affect the risk of all-cause mortality at 30 days?

STUDY DESIGN AND METHODS: This prospective monocentric registry included consecutive patients with CS of any cause from 2019 until 2021. First, the prognostic impact of the place of CS onset (out-of-hospital, ie, primary CS vs during hospitalization, ie, secondary CS) was investigated. Thereafter, the prognostic impact of the onset time of out-of-hospital CS was investigated. Furthermore, the prognostic impact of causative AMI vs non-AMI was investigated. Statistical analyses included Kaplan-Meier analyses, and univariable and multivariable Cox regression analyses.

RESULTS: Two hundred seventy-three patients with CS were included prospectively (64% with primary out-of-hospital CS). The place of CS onset was not associated with increased risk of all-cause mortality within the entire study cohort (secondary in-hospital CS: hazard ratio [HR], 1.532; 95% CI, 0.990-2.371; P = .06). However, increased risk of 30-day all-cause mortality was seen in patients with AMI related secondary in-hospital CS (HR, 2.087; 95% CI, 1.126-3.868; P = .02). Furthermore, primary out-of-hospital CS admitted during off-hours was associated with lower risk of all-cause mortality compared to primary CS admitted during on-hours (HR, 0.497; 95% CI, 0.302-0.817; P = .01), irrespective of the presence or absence of AMI.

INTERPRETATION: Primary and secondary CS were associated with comparable, whereas primary out-of-hospital CS admitted during off-hours was associated with lower risk of all-cause mortality at 30 days.

TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT05575856; URL: www.

CLINICALTRIALS: gov.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Behnes M, Rusnak J, Egner-Walter S, et al. Effect of Admission and Onset Time on the Prognosis of Patients With Cardiogenic Shock. Chest. 2023. PMID: 37579943. doi:10.1016/j.chest.2023.08.011

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。